Showing results (111-120 of 172) with videos related to

Sort By:
Pageof 18
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 17, 2011
Phenytoin toxicity in a patient receiving concomitant use of phenytoin and S-1 plus cisplatin chemotherapy for advanced gastric cancerKenji Mimatsu, Takatsugu Oida, Atsushi Kawasaki, et al.
Case Reports in Gastroenterology|April 25, 2014
Gastric Cancer Arising from an Upside-Down Stomach through a Paraesophageal Hiatal HerniaKenji Mimatsu, Hisao Kano, Takatsugu Oida, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 23, 2015
[Examination of the Response Rate of Paclitaxel and Bevacizumab Therapy for Metastatic Advanced Breast Cancer According to the Lymphopenia Grade]Shuhei Suzuki, Kenichi Sakurai, Keita Adachi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 23, 2015
[Study of the Response Rate and Neutrophil Lymphocyte Ratio in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy]Keita Adachi, Kenichi Sakurai, Shuhei Suzuki, et al.
Hepato-Gastroenterology|July 24, 2012
Anterior vs. posterior mediastinal routes in colon interposition after esophagectomyTakatsugu Oida, Kenji Mimatsu, Hisao Kano, et al.
Hepato-Gastroenterology|July 24, 2012
Spleen enlargement after distal gastrectomy in patients without hepatitisTakatsugu Oida, Kenji Mimatsu, Hisao Kano, et al.
Hepato-Gastroenterology|September 24, 2011
Protection of major vessels and pancreaticogastrostomy using the falciform ligament and greater omentum for preventing pancreatic fistula in soft pancreatic texture after pancreaticoduodenectomyKenji Mimatsu, Takatsugu Oida, Hisao Kano, et al.
Hepato-Gastroenterology|January 12, 2012
Double stents: airway stenting after esophageal-stent implantation for esophageal cancerTakatsugu Oida, Kenji Mimatsu, Hisao Kano, et al.
Hepato-Gastroenterology|November 17, 2011
Laparoscopic cystogastrostomy via the posterior approach for pancreatic pseudocyst drainageTakatsugu Oida, Kenji Mimatsu, Hisao Kano, et al.
Medical Molecular Morphology|May 27, 2015
Immunohistochemical co-expression status of cytokeratin 5/6, androgen receptor, and p53 as prognostic factors of adjuvant chemotherapy for triple negative breast cancerTetsuyo Maeda, Yoko Nakanishi, Yukari Hirotani, et al.
Pageof 18